Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association. Stemler, J., de Jonge, N., Skoetz, N., Sinkó, J., Brüggemann, R. J, Busca, A., Ben-Ami, R., Ráčil, Z., Piechotta, V., Lewis, R., & Cornely, O. A The Lancet Haematology, 9(5):e361 – e373, 2022. Cited by: 47
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association [link]Paper  doi  bibtex   
@ARTICLE{Stemler2022e361,
	author = {Stemler, Jannik and de Jonge, Nick and Skoetz, Nicole and Sinkó, János and Brüggemann, Roger J and Busca, Alessandro and Ben-Ami, Ronen and Ráčil, Zdeněk and Piechotta, Vanessa and Lewis, Russell and Cornely, Oliver A},
	title = {Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association},
	year = {2022},
	journal = {The Lancet Haematology},
	volume = {9},
	number = {5},
	pages = {e361 – e373},
	doi = {10.1016/S2352-3026(22)00073-4},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129779589&doi=10.1016%2fS2352-3026%2822%2900073-4&partnerID=40&md5=2af199d35cd54fae43aacb07d0626b36},
	type = {Review},
	publication_stage = {Final},
	source = {Scopus},
	note = {Cited by: 47}
}

Downloads: 0